文献速递皮肤肿瘤

病理学家特征与黑素细胞病变高级别诊断的关联

Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions.
PubMed 文献 · JAMA Dermatol · 2023-01-01

本研究基于两项全国性研究(M-Path与REMI),分析338名病理学家对黑素细胞病变的诊断倾向。结果显示,皮肤病理专科培训与更倾向于诊断高级别病变及pT1a侵袭性黑色素瘤相关,但该差异仅源于无核分裂活性的pT1a黑色素瘤。

要点

  • 皮肤病理专科培训者更易将病变诊断为高级别(OR 2.63)和侵袭性黑色素瘤(OR 1.95)。
  • 侵袭性黑色素瘤诊断差异仅由无核分裂活性的pT1a黑色素瘤驱动。
  • 皮肤病理学家中,黑素细胞病变工作负荷更高者更倾向高级别诊断(OR趋势 1.27)。

核心结论

  • 皮肤病理专科培训与更倾向于将非典型黑素细胞增生诊断为pT1a黑色素瘤相关。

研究设计与样本

  • 探索性研究,使用两项全国性研究(M-Path,2013年7月至2016年5月;REMI,2018年8月至2021年3月)的数据,共纳入338名病理学家(M-Path:113名普通病理学家和74名皮肤病理学家;REMI:151名皮肤病理学家)。
  • 每名病理学家被随机分配解读一组研究病例,每例由多名病理学家独立解读。

主要发现

  • 专科培训(委员会认证和/或专科进修)是与更严重诊断相关的主要因素:高级别诊断OR 2.63(95% CI 2.10-3.30,P < .001),侵袭性黑色素瘤诊断OR 1.95(95% CI 1.53-2.49,P < .001)。
  • 非核分裂活性pT1a诊断解释了侵袭性黑色素瘤诊断的差异;当这些低转移风险病变归入较轻诊断时,关联无统计学意义(OR 0.95,95% CI 0.74-1.23,P = .71)。
  • 在皮肤病理学家中,黑素细胞病变工作负荷更高者更可能给出高级别诊断(趋势OR 1.27,95% CI 1.04-1.56,P = .02)。

临床怎么用

  • 解读黑素细胞病变时,应考虑病理学家专科培训背景及工作负荷对诊断分级的影响。
  • 对无核分裂活性的pT1a黑色素瘤诊断需谨慎,避免过度诊断。

局限性

  • 本研究为探索性研究,结果需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The incidence of melanoma diagnoses has been increasing in recent decades, and controlled studies have indicated high histopathologic discordance across the intermediate range of melanocytic lesions. The respective causes for these phenomena remain incompletely understood. OBJECTIVE: To identify pathologist characteristics associated with tendencies to diagnose melanocytic lesions as higher grade vs lower grade or to diagnose invasive melanoma vs any less severe diagnosis. DESIGN, SETTING, AND PARTICIPANTS: This exploratory study used data from 2 nationwide studies (the Melanoma Pathology [M-Path] study, conducted from July 2013 to May 2016, and the Reducing Errors in Melanocytic Interpretations [REMI] study, conducted from August 2018 to March 2021) in which participating pathologists who interpreted melanocytic lesions in their clinical practices interpreted study cases in glass slide format. Each pathologist was randomly assigned to interpret a set of study cases from a repository of skin biopsy samples of melanocytic lesions; each case was independently interpreted by multiple pathologists. Data were analyzed from July 2022 to February 2023. MAIN OUTCOMES AND MEASURES: The association of pathologist characteristics with diagnosis of a study case as higher grade (including severely dysplastic and melanoma in situ) vs lower grade (including mild to moderately dysplastic nevi) and diagnosis of invasive melanoma vs any less severe diagnosis was assessed using logistic regression. Characteristics included demographics (age, gender, and geographic region), years of experience, academic affiliation, caseload of melanocytic lesions in their practice, specialty training, and history of malpractice suits. RESULTS: A total of 338 pathologists were included: 113 general pathologists and 74 dermatopathologists from M-Path and 151 dermatopathologists from REMI. The predominant factor associated with rendering more severe diagnoses was specialist training in dermatopathology (board certification and/or fellowship training). Pathologists with this training were more likely to render higher-grade diagnoses (odds ratio [OR], 2.63; 95% CI, 2.10-3.30; P < .001) and to diagnose invasive melanoma (OR, 1.95; 95% CI, 1.53-2.49; P < .001) than pathologists without this training interpreting the same case. Nonmitogenic pT1a diagnoses (stage pT1a melanomas with no mitotic activity) accounted for the observed difference in diagnosis of invasive melanoma; when these lesions, which carry a low risk of metastasis, were grouped with the less severe diagnoses, there was no observed association (OR, 0.95; 95% CI, 0.74-1.23; P = .71). Among dermatopathologists, those with a higher caseload of melanocytic lesions in their practice were more likely to assign higher-grade diagnoses (OR for trend, 1.27; 95% CI, 1.04-1.56; P = .02). CONCLUSIONS AND RELEVANCE: The findings suggest that specialty training in dermatopathology is associated with a greater tendency to diagnose atypical melanocytic proliferations as pT1a melanomas. These low-risk melanomas constitute a growing proportion of melanomas diagnosed in the US.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Kerr KF, Elder DE, Piepkorn MW, et al. Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions. JAMA Dermatol. 2023. PMID: 37938821. doi:10.1001/jamadermatol.2023.4334

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。